药物发现,开发和制造 499条(本栏目收费,不能显示细节,电话15274084725)
CLEARANCE OF NANOPARTICLES
DURING CIRCULATION 15150
DRUG DELIVERY STRATEGIES FOR
COMBATING MULTIPLE DRUG
RESISTANCE 15182
INTRACELLULAR TRAFFICKING OF
NANOPARTICLES: IMPLICATIONS
FOR THERAPEUTIC EFFICACY OF
THE ENCAPSULATED DRUG 15202
TOXICOLOGICAL ASSESSMENT OF NANOMEDICINE 15222
BIODEGRADABLE NANOPARTICLES 10985
RECOMBINANT SACCHAROMYCES
CEREVISIAE AS NEW DRUG
DELIVERY SYSTEM TO GUT: IN VITRO
VALIDATION AND ORAL
FORMULATION 11015
NASAL DELIVERY OF PEPTIDE AND
NONPEPTIDE DRUGS 11041
NASAL POWDER DRUG DELIVERY 11101
AEROSOL DRUG DELIVERY 11133
OCULAR DRUG DELIVERY 11179
MICROEMULSIONS AS DRUG
DELIVERY SYSTEMS 11219
TRANSDERMAL DRUG DELIVERY 11243
VAGINAL DRUG DELIVERY 11259
PHARMACEUTICAL
PREFORMULATION:
PHYSICOCHEMICAL PROPERTIES OF
EXCIPIENTS AND POWDERS AND
TABLET CHARACTERIZATION 11329
ROLE OF PREFORMULATION IN
DEVELOPMENT OF SOLID
DOSAGE FORMS 11381
TABLET PRODUCTION SYSTEMS 11501
CONTROLLED RELEASE OF DRUGS
FROM TABLET COATINGS 11547
EFFECTS OF GRINDING IN
PHARMACEUTICAL TABLET
PRODUCTION 11613
ORAL EXTENDED - RELEASE
FORMULATIONS 11639
CYCLODEXTRIN - BASED
NANOMATERIALS IN
PHARMACEUTICAL FIELD 11671
NANOTECHNOLOGY IN
PHARMACEUTICAL
MANUFACTURING 11695
PHARMACEUTICAL
NANOSYSTEMS: MANUFACTURE,
CHARACTERIZATION, AND
SAFETY 11735
OIL - IN - WATER NANOSIZED
EMULSIONS: MEDICAL APPLICATIONS 117733
GOOD MANUFACTURING
PRACTICES ( GMP ) AND RELATED
FDA GUIDELINES 11813
ENFORCEMENT OF CURRENT GOOD
MANUFACTURING PRACTICES 11855
SCALE - UP AND POSTAPPROVAL
CHANGES (SUPAC) REGULATIONS 11877
SCALE - UP AND POSTAPPROVAL
CHANGES (SUPAC) REGULATIONS 11907
NATIONAL GMP REGULATIONS AND
CODES AND INTERNATIONAL GMP
GUIDES AND GUIDELINES:
CORRESPONDENCES AND
DIFFERENCES 11927